Immutep Ltd
Immutep Limited, a biotechnology company, engages in developing novel Lymphocyte Activation Gene-3 related immunotherapies for cancer and autoimmune diseases in Australia. Its lead product candidate is the eftilagimod alfa (efti or IMP321), a soluble LAG-3lg fusion based on LAG-3 immune control mechanism for the treatment of different types of cancers. The company's product pipeline also includes… Read more
Immutep Ltd (IMM) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: -0.233x
Based on the latest financial reports, Immutep Ltd (IMM) has a cash flow conversion efficiency ratio of -0.233x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-33.50 Million) by net assets (AU$143.64 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Immutep Ltd - Cash Flow Conversion Efficiency Trend (2004–2025)
This chart illustrates how Immutep Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Immutep Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Immutep Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Provision Information Co.Ltd.
TWO:6590
|
0.036x |
|
OCI International Holdings Limited
PINK:DGTLF
|
-0.029x |
|
theglobe.com Inc
PINK:TGLO
|
0.015x |
|
BitNine Co. Ltd.
KQ:357880
|
-0.127x |
|
SinoMedia Holding Limited
F:SJY
|
0.010x |
|
Knaus Tabbert AG
XETRA:KTA
|
-0.133x |
|
Precious Shipping Public Company Limited
PINK:PSGFF
|
0.038x |
|
PAMT CORP
NASDAQ:PAMT
|
0.028x |
Annual Cash Flow Conversion Efficiency for Immutep Ltd (2004–2025)
The table below shows the annual cash flow conversion efficiency of Immutep Ltd from 2004 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | AU$143.64 Million | AU$-62.05 Million | -0.432x | -135.12% |
| 2024-06-30 | AU$189.52 Million | AU$-34.82 Million | -0.184x | +30.12% |
| 2023-06-30 | AU$136.47 Million | AU$-35.88 Million | -0.263x | +18.17% |
| 2022-06-30 | AU$94.08 Million | AU$-30.23 Million | -0.321x | -33.47% |
| 2021-06-30 | AU$73.27 Million | AU$-17.64 Million | -0.241x | +26.04% |
| 2020-06-30 | AU$33.30 Million | AU$-10.84 Million | -0.326x | +48.07% |
| 2019-06-30 | AU$24.39 Million | AU$-15.29 Million | -0.627x | -176573.57% |
| 2018-06-30 | AU$33.52 Million | AU$-11.89K | 0.000x | +99.89% |
| 2017-06-30 | AU$26.53 Million | AU$-8.51 Million | -0.321x | -0.12% |
| 2016-06-30 | AU$35.32 Million | AU$-11.31 Million | -0.320x | -1.53% |
| 2015-06-30 | AU$24.69 Million | AU$-7.79 Million | -0.315x | +49.92% |
| 2014-06-30 | AU$22.59 Million | AU$-14.23 Million | -0.630x | -14.85% |
| 2013-06-30 | AU$29.25 Million | AU$-16.04 Million | -0.548x | -6.56% |
| 2012-06-30 | AU$37.16 Million | AU$-19.12 Million | -0.515x | -190.62% |
| 2011-06-30 | AU$55.10 Million | AU$-9.76 Million | -0.177x | +54.00% |
| 2010-06-30 | AU$16.79 Million | AU$-6.46 Million | -0.385x | +62.96% |
| 2009-06-30 | AU$1.81 Million | AU$-1.88 Million | -1.039x | -76.06% |
| 2008-06-30 | AU$2.63 Million | AU$-1.55 Million | -0.590x | +27.67% |
| 2007-06-30 | AU$4.08 Million | AU$-3.33 Million | -0.816x | -2.03% |
| 2006-06-30 | AU$6.32 Million | AU$-5.05 Million | -0.800x | -40.92% |
| 2005-06-30 | AU$8.34 Million | AU$-4.73 Million | -0.568x | +48.43% |
| 2004-06-30 | AU$5.13 Million | AU$-5.64 Million | -1.100x | -- |